help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Légrádi, G.
Right arrow Articles by Lechan, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Légrádi, G.
Right arrow Articles by Lechan, R. M.
Endocrinology Vol. 138, No. 6 2569-2576
Copyright © 1997 by The Endocrine Society


ARTICLES

Leptin Prevents Fasting-Induced Suppression of Prothyrotropin-Releasing Hormone Messenger Ribonucleic Acid in Neurons of the Hypothalamic Paraventricular Nucleus1

Gábor Légrádi, Charles H. Emerson, Rexford S. Ahima, Jeffrey S. Flier and Ronald M. Lechan

Tupper Research Institute and Department of Medicine, Division of Endocrinology, Diabetes, Metabolism and Molecular Medicine, New England Medical Center (G.L., R.M.L.) and Department of Medicine, Division of Endocrinology, Beth Israel-Deaconess Medical Center (R.S.A., J.S.F.), Boston, Massachusetts 02111; University of Massachusetts Medical School (C.H.E.), Worcester, Massachusetts 01655; and Department of Neuroscience (R.M.L.), Tufts University School of Medicine, Boston, Massachusetts 02111

Address all correspondence and requests for reprints to: Ronald M. Lechan, M.D., Ph.D., Professor of Medicine, Division of Endocrinology, Box No. 268, New England Medical Center, 750 Washington Street, Boston, Massachusetts 02111.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Prolonged fasting is associated with a number of changes in the thyroid axis manifested by low serum T3 and T4 levels and, paradoxically, low or normal TSH. This response is, at least partly, caused by suppression of proTRH gene expression in neurons of the hypothalamic paraventricular nucleus (PVN) and reduced hypothalamic TRH release. Because the fall in thyroid hormone levels can be blunted in mice by the systemic administration of leptin, we raised the possibility that leptin may have an important role in the neuroendocrine regulation of the thyroid axis, through effects on hypophysiotropic neurons producing proTRH. Adult male, Sprague-Dawley rats were either fed normally, fasted for 3 days, or fasted and administered leptin at a dose of 0.5 µg/gm BW ip every 6 h. Fasted animals showed significant reduction in plasma total and free T4 and T3 levels compared with controls, that were restored toward normal by the administration of leptin. Percent free T4, but not percent free T3, increased during fasting, further suggesting a reduction in plasma transthyretin levels that did not return to fed levels after leptin administration. By semiquantitative analysis of in situ hybridization autoradiograms, proTRH messenger RNA in medial parvocellular PVN neurons was markedly suppressed in the fasting animals but was restored to normal by leptin administration [fed vs. fast vs. fast/leptin (density units x 108): 8.5 ± 0.4, 3.2 ± 0.2, 8.1 ± 0.8]. In contrast, proTRH messenger RNA in adjacent neurons in the lateral hypothalamus that do not have a hypophysiotropic function remained unchanged by any of the experimental manipulations. These findings indicate that leptin has a selective, central action to modulate the hypothalamic-pituitary-thyroid axis by regulating proTRH gene expression in the PVN but does not have peripheral effects on thyroid-binding proteins. We propose that the fall in circulating leptin levels during fasting resets the set point for feedback inhibition by thyroid hormones on the biosynthesis of hypophysiotropic proTRH, thereby allowing adaptation to starvation.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
PROLONGED FASTING has profound effects on the hypothalamic-pituitary-thyroid axis in rats, manifested by low plasma T3, T4, free T3, and free T4 and low or normal levels of TSH (1, 2, 3, 4, 5, 6, 7, 8, 9). In addition, fasting results in reduced content of TSH and ßTSH messenger RNA (mRNA) in the anterior pituitary, reduced proTRH mRNA in the hypothalamic paraventricular nucleus (PVN) [the origin of TRH-producing neurons responsible for regulation of anterior pituitary TSH secretion (10)], and a decrease in the concentration of TRH in hypophysial portal blood (2, 7, 8, 9). In altered states of thyroid function (hypothyroidism and hyperthyroidism), the biosynthesis of TRH in hypophysiotropic TRH neurons changes inversely with plasma concentrations of T4 and T3 (11, 12, 13, 14). During fasting, therefore, when circulating levels of thyroid hormone are low, the reduction of proTRH gene expression in the PVN and decreased concentration of TRH in the portal capillary system seem paradoxical, suggesting that the set point for thyroid hormone feedback regulation of TRH biosynthesis in the PVN is altered. The mechanisms for this phenomenon, however, have not been fully explained.

Systemic administration of leptin, an endogenous protein hormone with anorectic activity synthesized and secreted by fat cells (15), blunts the fall in T4 levels during fasting and blunts changes in the adrenal and gonadal axes (16). Because leptin levels are normally suppressed by fasting (17, 18), it was proposed that falling leptin levels provide an important signal that coordinates a number of endocrine responses to starvation, including decreased thyroid thermogenesis, increased stress steroids, and inhibition of reproductive function (16). Because leptin can effect the brain to alter neuropeptide Y mRNA in the arcuate nucleus (19), we hypothesized that the circulating levels of leptin also may be involved in the neuroendocrine regulation of hypophysiotropic proTRH-producing neurons in the PVN during fasting, to explain changes in peripheral thyroid hormone levels. In this study, therefore, we measured the content of proTRH mRNA in the hypothalamus of normally fed and fasted rats and determined whether systemic administration of leptin to fasted rats could have any effect on proTRH biosynthesis in the PVN.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals
A total of 24 male Sprague-Dawley rats (Taconic Farms, Germantown, NY), weighing 180–215 g, were acclimatized to a 12-h light/12-h dark cycle (lights between 0600 and 1800 h) and controlled temperature (22 ± 1 C) before the procedures. Rat chow and tap water were provided ad libitum. All experimental protocols were reviewed and approved by the animal welfare committee at the New England Medical Center and Tufts University School of Medicine (Boston, MA).

Experimental protocol
Animals were divided into three groups of eight animals each. The first group was allowed free access to food and water; the second group was fasted for approximately 65 h, beginning at 1600 h the first day and ending between 0900 and 1100 h on the last day, but allowed continued access to drinking water; and the third group was fasted as above and administered recombinant leptin (Eli Lilly and Co., Indianapolis, IN) at a dose of 0.5 µg/gm BW ip every 6 h beginning two h after the removal of food. All animals were weighed daily, and at completion of the experiment, they were anesthetized with pentobarbital (50 mg/kg BW, ip); blood was obtained from the inferior vena cava for measurement of serum T3, T4, free T3, free T4, TSH, and thyroid-binding proteins and immediately perfused with fixative as described below. Blood was collected into polypropylene tubes, centrifuged for 15 min at 3500 rpm, and the plasma stored at -80 C until assayed.

Tissue preparation
After general anesthesia, animals were perfused through the ascending aorta with 0.01 M PBS, pH 7.2, containing 15,000 U/liter heparin sulfate for 30–60 sec, followed by 4% paraformaldehyde in PBS for 15 min. Brains were removed, postfixed by immersion in the same fixative for 6 h, and placed in 20% sucrose in PBS at 4 C overnight. Serial 18-µm coronal tissue sections through the rostral-caudal extent of the PVN were obtained on a cryostat (Reichert-Jung 2800 Frigocut-E) and adhered to Superfrost/Plus glass slides (Fisher Scientific Co., Pittsburgh, PA) to obtain four sets of slides (each set containing every fourth tissue section through the PVN). The tissue sections were desiccated overnight by heating at 42 C and stored at -80 C until prepared for in situ hybridization histochemistry.

In situ hybridization histochemistry
Every fourth section taken from the region of the PVN was hybridized with a single-stranded, [35S]UTP-labeled complementary RNA probe generated from a 1241-bp EcoRI-PstI fragment of proTRH complementary DNA cloned antisense into the plasmid vector pSP65 (Promega Corp., Madison, WI), as previously described (11, 20). Specificity of hybridized material in the PVN and lateral hypothalamus, as proTRH mRNA with this probe, has been established in previous publications showing the absence of hybridization in the hypothalamus with a noncomplementary probe transcribed from the same 1241-bp fragment, a single hybridizing band of approximately 1.6 kb by Northern hybridization corresponding to the expected size of proTRH mRNA in RNA extracts of the PVN, and an identical distribution of hybridized cells in the brain with a different complementary probe recognizing the 3' untranslated region of proTRH mRNA (11, 20, 21). Hybridization was performed under plastic coverslips in buffer containing 50% formamide, a 2-fold concentration of standard sodium citrate, 10% dextran sulfate, 0.25% BSA, 0.25% Ficoll 400, 0.25% polyvinylpyrrolidone 360, 250 mM Tris (pH 7.5), 0.5% sodium pyrophosphate, 0.5% SDS, 250 mg/ml denatured salmon sperm DNA, and 6 x 105 cpm of the radiolabeled probe, for 16 h at 55 C. Slides were dipped into Kodak NTB2 autoradiography emulsion (Eastman Kodak, Rochester, NY) and the autoradiograms developed after 3 days of exposure at 4 C.

Image analysis
Autoradiograms of the PVN and, for comparison, the lateral hypothalamus in the same tissue sections were visualized at x78 under darkfield illumination with a Zeiss binocular microscope fitted with a COHU solid-state TV camera (San Diego, CA). The intensity of the light source was maintained constant by conversion of AC current through a DC power supply (EPSCO, Addison, IL). The images were captured with a Data Translation Quick Capture frame grabber board (Marlboro, MA) and analyzed with a Quadra Macintosh computer using Image 1.52 (NIH). Background density points were removed by thresholding the image, and integrated density values (density x area) of hybridized neurons in the same region on each side of the PVN were measured in each animal. Nonlinearity of radioactivity in the emulsion was evaluated by comparing density values with a calibration curve created from autoradiograms of known dilutions of the radiolabeled probe immobilized on glass slides, in 1% gelatin, that had been exposed and developed simultaneously with the in situ hybridization autoradiograms. Values corresponding to the content of proTRH mRNA in the PVN or lateral hypothalamus were calculated for each animal by summing the integrated density values on each side of the PVN from four consecutive sections, as previously described (22).

Hormone measurements
Plasma T3, T4, and TSH concentrations were measured by RIA. Materials for the TSH RIA were provided by the NIADDK National Hormone and Pituitary Program (Baltimore, MD) using NIDDK rat TSH RP-2 as the standard. Plasma T3 and T4 levels were measured with specific RIAs using antiserum from Ventrex (Portland, ME) and [125I]-labeled T3 or T4 obtained from New England Nuclear (Boston, MA). Equilibrium dialysis was employed to determine the fraction of T4 and T3 in plasma that was free. The details of the assay have been reported previously (23). The COBRA 500 program was used for data reduction and calculation of the RIA results.

Statistical analysis
Results are presented as means ± SEM. Statistical significance between control and experimental groups was determined by ANOVA, followed by Student-Newman-Keuls multiple comparisons test. Differences were considered to be significant at P < 0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Effect of fasting and leptin administration on body weight and plasma hormone levels
Fasted animals had an approximately 28% mean reduction in body weight at termination of the experiment, compared with controls [fed vs. fasted (mean ± SEM): 228 ± 3 g vs. 160 ± 3 g, P < 0.001]. Fasted animals receiving leptin also showed a significant reduction in BW \[164 ± 2 g\] that was not significantly different from the weight loss of the fasted animals.

Results of plasma thyroid hormone and TSH determinations are shown in Table 1Go. Table 1Go also shows data for the free (nonprotein-bound) T4 and free T3 fractions in plasma, as determined by equilibrium dialysis. As expected, plasma T4 and T3 concentrations were reduced significantly in fasted rats. In contrast, leptin had a profound influence on the effect of fasting on plasma total and free thyroid hormone concentrations. Serum T4 concentrations were only slightly lower in fasted rats that were treated with leptin, compared with fed rats, and serum free T4 concentrations in leptin-treated fasted rats were actually higher than in fed rats. Similarly, whereas serum total and free T3 were significantly lower in fasted than in fed rats, fasted rats treated with leptin had plasma T3 concentrations comparable with those of fed rats. Plasma free T4 and free T3 concentrations, calculated by multiplying total plasma concentrations by the free fraction, showed that fasting was associated with an increase in the free fraction of T4 but not in the free fraction of T3. The increase in the free T4 fraction was not statistically different in fasted rats that received leptin, compared with those not treated with leptin. Mean plasma TSH concentrations were slightly lower in fasted, compared with fed rats or fasted leptin-treated rats, but differences among the groups were not significant.


View this table:
[in this window]
[in a new window]
 
Table 1. Thyroid hormone levels in normally fed animals, 3-day fasted animals and fasted animals receiving leptin

 
Effect of fasting and leptin administration on proTRH mRNA in the hypothalamus
In control animals, neurons containing proTRH mRNA were readily visualized by in situ hybridization histochemistry, symmetrically distributed in parvocellular neurons of the PVN on either side of the third ventricle (Fig. 1Go, A and B). ProTRH-producing neurons were located primarily in the medial and periventricular subdivisions of the PVN underlying the third ventricle in midportions of the PVN (Fig. 1AGo) and clustered into a dense network of cells in a triangular configuration in the medial parvocellular subdivision of the PVN in more caudal portions of the nucleus (Fig. 1BGo). Intense hybridization was present also in adjacent neurons in the lateral hypothalamus (Fig. 2Go).



View larger version (97K):
[in this window]
[in a new window]
 
Figure 1. Darkfield illumination photomicrographs of proTRH mRNA in mid (A, C, and E) and caudal (B, D, and F) regions of the hypothalamic PVN in fed (A and B), fasted (C and D), and fasted animals receiving leptin (E and F). Note the marked reduction in silver grains over neurons in the PVN in the fasted animals but restoration to normal in the fasted animals receiving leptin. III, third ventricle; original magnification, x62.5; scale bar = 200 µm.

 


View larger version (74K):
[in this window]
[in a new window]
 
Figure 2. Low power darkfield photomicrograph of proTRH mRNA in the hypothalamus of fed (A), fasted (B), and fasted animals receiving leptin (C), showing the contrast between silver grain accumulation over paraventricular neurons (arrow) and neurons in the lateral hypothalamus (LH). Note in B that fasting results in a reduction in proTRH mRNA in the PVN but does not seem to affect hybridization in the LH. III, third ventricle; original magnification, x30; scale bar = 200 µm.

 
In fasted animals, neurons containing proTRH mRNA were observed in an identical distribution in the PVN but showed substantial reduction in the accumulation of silver grains over neurons (Fig. 1Go, C and D). No apparent reduction in hybridization signal over neurons in the lateral hypothalamus was noted (Fig. 2Go, A and B). In contrast, fasted animals receiving leptin showed a hybridization pattern over PVN neurons that seemed identical to the fed animals (Fig. 1Go, E and F). No differences in the intensity of the hybridization signal were noted in the lateral hypothalamus (Fig. 2CGo).

By image analysis, the total density value for proTRH mRNA in the PVN in fasted animals was reduced to approximately 62% of fed animals but, after leptin administration, was restored to normal (Fig. 3AGo). Density values of the lateral hypothalamus in fed, fasted, and fasted animals receiving leptin were unchanged (Fig. 3BGo).



View larger version (19K):
[in this window]
[in a new window]
 
Figure 3. Computerized image analysis of proTRH mRNA content in the PVN (A) and lateral hypothalamus (B) of fed, fasted, and fasted animals receiving leptin. *, P < 0.001, compared with fasted animals.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Thyroid hormone is of life-sustaining importance in most mammalian species (24). Consequently, the plasma levels of T4 and T3 are carefully protected by a precise homeostatic feedback mechanism residing in the hypothalamus and anterior pituitary (25, 26). This feedback control system is dependent upon the secretion of TRH into the portal capillary plexus to modulate the set point of feedback regulation by thyroid hormone on TSH secretion from the anterior pituitary gland. When circulating levels of thyroid hormone fall, the biosynthesis of proTRH in the medial and periventricular parvocellular subdivisions of the hypothalamic PVN increase, mediated by a direct action of T3 and T4 on hypophysiotropic TRH neuronal cell bodies (11, 12, 13, 14). This leads to increased secretion of TRH and products of proTRH into the portal capillary plexus for conveyance to anterior pituitary thyrotropes (27, 28, 29) and, by raising the threshold for feedback regulation by thyroid hormone, increases the secretion of TSH. Conversely, when circulating thyroid hormone levels are elevated, the biosynthesis of TRH in hypophysiotropic PVN neurons is inhibited (11, 13). This reduces the secretion of TRH into the portal system (30) and, by reducing the threshold for feedback regulation by thyroid hormone on anterior pituitary thyrotropes, reduces the secretion of TSH. Thus, an inverse relationship between circulating levels of thyroid hormone and the biosynthesis and secretion of hypophysiotropic TRH exists to maintain normal circulating levels of thyroid hormone.

In response to environmental stressors and under certain pathological conditions, however, the hypothalamic-pituitary-thyroid axis rapidly readjusts its set point for feedback regulation by thyroid hormone, presumably in a way that is beneficial to the survival of the organism under these adverse circumstances. Cold exposure, for example, causes elevation of thyroid hormone levels, but it is associated also with increased expression of proTRH in hypophysiotropic neurons in the PVN and increased secretion of TSH (31, 32, 33, 34, 35), presumably as an adaptive response, to increase thermogenesis. Conversely, during fasting or infection, there is a fall in thyroid hormone levels, but a reduction in proTRH mRNA, in the PVN and inappropriately low or normal levels of plasma TSH (1, 2, 3, 4, 5, 6, 7, 8, 9, 36), presumably as an adaptive response to reduce thermogenesis and preserve nitrogen stores (37, 38, 39). The signals that override the normal physiological control mechanism of feedback regulation by thyroid hormone on hypophysiotropic proTRH neurons and reset the thyrostat in these PVN neurons are poorly understood. On the basis that the systemic administration of leptin, a fat cell-derived protein with important effects in mediating energy conservation (40), restored plasma levels of thyroid hormone to normal in fasting mice (16), we raised the possibility that the concentration of leptin in the circulation may be an important signal that establishes the set point for feedback regulation by thyroid hormone on these hypophysiotropic proTRH neurons. To begin to test this hypothesis, we determined whether leptin has a central action on proTRH-producing neurons in the PVN to regulate its biosynthesis.

As noted in previous studies (1, 2, 3, 4, 5, 6, 7, 8, 9), we observed also that fasted results in a significant decrease in plasma total and free T4 and T3 levels, a small (although insignificant) reduction in plasma TSH, and a significant reduction in proTRH mRNA in the PVN. Systemic administration of leptin to the fasted animals, however, prevented the fall in total and free T3 levels, whereas total T4 approached normal, and free T4 actually exceeded, the normal values in fed animals. As observed for total and free thyroid hormone levels, the systemic administration of leptin also prevented the reduction in proTRH mRNA in the PVN, resulting in levels that were not significantly different from the fed animals. This effect was specific for proTRH-synthesizing neurons in the PVN, because no effects of leptin were observed on adjacent proTRH-producing neurons in the lateral hypothalamus that do not have a hypophysiotropic function (41). These data demonstrate that leptin has a potent action on the hypothalamic-pituitary-thyroid axis in fasting animals to restore the reduced thyroid hormone levels to normal by increasing the biosynthesis of hypophysiotropic proTRH. By inference, therefore, the reduction in circulating thyroid hormones that occurs with fasting, simultaneously with a fall in leptin levels (17, 18), may be caused by an effect of falling plasma leptin levels to decrease the set point (increase the sensitivity) for feedback regulation of thyroid hormone on proTRH hypophysiotropic neurons.

In contrast, fasting was associated with an increase in the free fraction of T4, but not the free fraction of T3, as demonstrated by equilibrium dialysis. This finding was noted regardless of whether fasted rats received leptin. Fasting has complex, gender-influenced effects on serum thyroid hormone-binding proteins (42). Serum transthyretin, a major thyroid hormone-binding protein in the rat, declines during fasting, whereas T4-binding globulin, present in only trace levels in the fed rat, becomes clearly detectable. The lack of an effect of leptin on the fasting-induced changes in the free, nonprotein-bound plasma T4 fraction suggests that leptin may not influence the effect of fasting on plasma thyroid hormone-binding proteins.

Although the decline in plasma TSH in fasted rats was not significant, the absence of a TSH rise in the presence of the substantial decline in free thyroid hormone levels is consistent with central hypothyroidism. TRH has an important role in the glycosylation of TSH, such that a reduction in TRH leads to TSH with less complex carbohydrate structures and reduced bioactivity that can be restored by TRH administration (43, 44, 45). Similarly, in man, hypothalamic hypothyroidism often is characterized by normal, or even slightly elevated, serum TSH concentrations (46) and, as demonstrated by Beck-Peccoz et al. (47), is associated with reduced TSH bioactivity and decreased receptor activity on thyroid membranes. It seems likely, therefore, that the biological activity of TSH in fasted animals is reduced because of a fall in pituitary portal blood concentrations of TRH. Leptin administration, in turn, probably restores TSH bioactivity by blocking the effects of fasting on the biosynthesis of proTRH.

The mechanism(s) by which falling leptin levels reduce proTRH gene expression in the PVN requires further study, but several possibilities should be considered. The first is that leptin exerts direct effects on proTRH neurons, after entering the PVN, through its rich vascular supply (48). Banks et al. (49) have shown recently that leptin can be transported efficiently across the blood brain barrier from the systemic circulation by a saturable mechanism, which (given the large size of the protein) indicates the presence of an active transport system. Receptor autoradiography (49, 50, 51, 52) and the distribution of leptin receptor mRNA by in situ hybridization histochemistry (19), however, indicate that the PVN is not a site for leptin binding in the brain. Nevertheless, leptin binding has been observed in the median eminence (49), the point of termination of proTRH-producing neurons in the PVN, raising the possibility that leptin could have receptors on the axon terminals of these neurons and thereby influence the secretion of proTRH-derived peptides into the portal circulation.

Leptin may affect proTRH gene expression indirectly through effects on the hypothalamic-pituitary-adrenal (HPA) axis. When administered into the cerebrospinal fluid, leptin is reported to increase CRH gene expression in the PVN (19). Because reciprocal synaptic interactions between CRH and proTRH neurons in the PVN have been observed by electron microscopy (53), it is possible that CRH could mediate the effects of leptin on hypophysiotropic proTRH neurons via these interactions. CRH inhibits TRH release from rat hypothalamus in culture (54), however, which would be contrary to the observation that leptin administration to fasted animals increases proTRH mRNA in the PVN. A more important effect of leptin on the HPA axis may be seen in the association between elevated plasma corticosterone levels and low leptin levels during fasting (55, 56, 57) and the ability of systemically administered leptin to attenuate the fasting-induced rise in corticosterone (16). This indicates that the rise in corticosterone during fasting may be mediated by falling levels of leptin, although the locus for its action on the HPA axis is not known. Because glucocorticoids have a cell-specific effect to reduce proTRH mRNA levels in the PVN (58), the fasting-induced suppression of proTRH gene expression and rescue by leptin administration may be indirect, associated with leptin mediated changes in circulating corticosterone levels. Indeed, van Haasteren et al. (9) have reported that in a substrain of female Wistar rats (R-Amsterdam), the fasting associated reduction in proTRH mRNA in the PVN can be altered if the rise in corticosterone is prevented by adrenalectomy and replacement with corticosterone to maintain normal basal plasma concentrations. Glucocorticoids are not likely the only mechanism to explain changes in the hypothalamic-pituitary-thyroid axis during fasting, however, because in van Haasteren’s study, fasting in adrenalectomized-corticosterone replaced rats still resulted in a fall in circulating thyroid hormone levels (9). In addition, substantial doses of glucocorticoids are required to achieve only modest reductions in proTRH mRNA in PVN neurons, and these doses are associated with weight loss (58).

One of the most important recognized actions of leptin is its role in the regulation of NPY gene expression in the hypothalamus (59). During fasting, when leptin levels are low (17, 18), arcuate nucleus NPY gene expression is markedly increased (60, 61, 62). Conversely, the systemic administration of leptin results in pronounced inhibition of NPY gene expression in the arcuate nucleus (16, 59, 63) and has been proposed by Glaum et al. (64), on the basis of their electrophysiological studies on hypothalamic slices, to reduce the activity of NPY-producing neurons in the arcuate nucleus and decrease the release of NPY in the PVN. The arcuate nucleus contains a high density of leptin receptor mRNA (19), indicating that leptin can have a direct, central action on NPY production in this region of the brain. Because NPY-producing neurons in the arcuate nucleus project heavily to the PVN (65) and injections of NPY into the PVN increases food intake (66), it is presumed that leptin signals the PVN about feeding and body weight by way of NPY-containing axonal projection pathways originating in the arcuate nucleus. NPY-containing axon terminals also make numerous synaptic contacts with proTRH-producing neurons in the PVN (67), which we now believe arise primarily from neurons in the arcuate nucleus (Légrádi and Lechan, unpublished observations). The possibility that leptin could modulate proTRH gene activity in the PVN via direct actions on NPY neurons in the arcuate nucleus, therefore, seems particularly attractive and would link the regulation of thyroid thermogenesis and feeding behavior to a single anatomical pathway. As we have hypothesized that NPY may be inhibitory to proTRH neurons on the basis of electron microscopic characteristics of the synaptic contacts between NPY-containing axon terminals and proTRH perikarya and dendrites (67), we would propose that when leptin levels fall, NPY gene expression is disinhibited, resulting in the increased release of NPY in the PVN. This increase would simultaneously exert effects on feeding behavior and lower the threshold for thyroid hormone feedback inhibition on proTRH gene expression. Nevertheless, mice with targeted deletion of the NPY gene have recently been shown to have a fall in T4 during a 48-h fast that is indistinguishable from control animals (J Erickson, R Ahima, G. Hollopeter, J. Flier, and R. Palmiter, submitted), indicating that other targets capable of mediating a central action on hypophysiotropic proTRH neurons must also exist.

Cytokines, responsible for many of the manifestations of infection, also are well recognized to result in low circulating thyroid hormone levels and inappropriately low or normal levels of TSH, resulting in a disorder commonly referred to in man as the sick euthyroid syndrome (36). Both IL-1 and TNF cause significant reductions in TSH levels in man after systemic administration (68, 69) and reduce the content of TRH or proTRH mRNA in the hypothalamus of experimental animals (70, 71). This raises the possibility that the effects of falling leptin levels on proTRH gene expression in the PVN could be mediated by activation of the cytokine system peripherally or in the brain. Endotoxin and cytokines induce the expression of leptin (72), however, suggesting that the effect of cytokines on the hypothalamic-pituitary-thyroid axis may occur by a mechanism independent of leptin.

In conclusion, we have observed that the fasting-induced reduction in proTRH mRNA in hypophysiotropic neurons of the hypothalamic PVN can be prevented by the systemic administration of leptin. These findings indicate that the fall in circulating leptin levels may act as the critical signal to hypophysiotropic neurons in the PVN to reset the set point for feedback regulation of proTRH gene expression by thyroid hormone. This mechanism would inhibit proTRH gene expression in the PVN during fasting, when circulating thyroid hormone levels are low, and by reducing thyroid thermogenesis, act in a coordinated fashion with other homeostatic mechanisms to allow adaptation to starvation.


    Acknowledgments
 
The authors appreciate the skillful assistance of Mr. Scott Stone and Mr. Sam Pino.


    Footnotes
 
1 This work was supported by Grants NIH-DK-37021 (to R.M.L.) and DK-28082 (to J.S.F.) and research support from Eli Lilly (to J.S.F.). Back

Received January 27, 1997.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Cambell GA, Kurcz M, Marshall S, Meitex J 1977 Effects of starvation in rats on serum levels of follicle stimulating hormone, luteinizing hormone, thyrotropin, growth hormone and prolactin; response to LH-releasing hormone and thyrotropin-releasing hormone. Endocrinology 100:580–587[Abstract]
  2. Harris RC, Fang S-L, Azizi F, Lipworth L, Vagenakis AG, Braverman LE 1978 Effect of starvation on hypothalamic-pituitary-thyroid function in the rat. Metabolism 27:1074–1083[CrossRef][Medline]
  3. Kinlaw WB, Schwartz HL, Oppenheimer JL 1985 Decreased serum triiodothyronine in starving rats is due primarily to diminished thyroidal secretion of thyroxine. J Clin Invest 75:1238–1241
  4. Connors JM, DeVito W, Hedge GA 1985 Effects of food deprivation on the feedback regulation of the hypothalamic-pituitary-thyroid axis of the rat. Endocrinology 117:900–906[Abstract]
  5. Hugues JN, Epelbaum J, Voirol MJ, Modigliani E, Sebaoun J, Enjalbert A 1988 Influence of starvation on hormonal control of hypophyseal secretion in rats. Acta Endocrinol (Copenh) 119:195–202[Medline]
  6. Cohen III JH, Alex S, DeVito WJ, Braverman LE, Emerson CH 1989 Fasting-associated changes in serum thyrotropin in the rat are influenced by gender. Endocrinology 124:3025–3029[Abstract]
  7. Blake NG, Eckland JA, Foster OJF, Lightman SL 1991 Inhibition of hypothalamic thyrotropin-releasing hormone messenger ribonucleic acid during food deprivation. Endocrinology 129:2714–2718[Abstract]
  8. Rondeel JMM, Heide R, deGreef WJ, van Toor H, van Haasteren GAC, Klootwijk W, Visser TJ 1992 Effect of starvation and subsequent refeeding on thyroid function and release of hypothalamic thyrotropin-releasing hormone. Neuroendocrinology 56:348–353[Medline]
  9. van Haasteren GAC, Linkels E, van Toor H, Rondeel JMM, Themmen APN, deJong FH, Valentijn K, Vaudry H, Bauer K, Visser TJ, deGreef WJ 1995 Starvation-induced changes in the hypothalamic content of prothyrotrophin-releasing hormone (proTRH) mRNA and the hypothalamic release of proTRH-derived peptides: role of the adrenal gland. J Endocrinol 145:143–153[Abstract]
  10. Lechan RM, Toni R 1992 Thyrotropin-releasing hormone neuronal systems in the central nervous system. In: Nemeroff CS (ed) Neuroendocrinology. CRC Press, Boca Raton, pp 279–330
  11. Segerson TP, Kauer J, Wolfe HC, Mobtaker H, Wu P, Jackson IMD, Lechan RM 1987 Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus. Science 238:78–80[Abstract/Free Full Text]
  12. Dyess EM, Segerson TP, Liposits Z, Paull WL, Kaplan MM, Wu P, Jackson IMD, Lechan RM 1988 Triiodothyronine exerts direct cell-specific regulation of thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus. Endocrinology 123:2291–2297[Abstract]
  13. Koller KJ, Wolff RS, Warden MK, Zoeller RT 1987 Thyroid hormones regulate levels of thyrotropin-releasing-hormone mRNA in the paraventricular nucleus. Proc Natl Acad Sci USA 84:7329–7333[Abstract/Free Full Text]
  14. Kakucska I, Rand W, Lechan RM 1992 Thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is dependent upon feedback regulation by triiodothyronine and thyroxine. Endocrinology 130:2845–2850[Abstract]
  15. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–432[CrossRef][Medline]
  16. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS Role of leptin in the neuroendocrine response to fasting. Nature 382:250–252
  17. Frederich RC, Lollmann B, Hamann A, Napolitano-Rosen A, Kahn BB, Lowell BB, Flier JS 1995 Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest 96:1658–1663
  18. Boden G, Chen X, Mozzoli M, Ryan I 1996 Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 81:3419–3423
  19. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG 1996 Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98:1101–1106[Medline]
  20. Lechan RM, Wu P, Jackson IMD, Wolfe H, Cooperman S, Mandel G, Goodman RH 1986 Thyrotropin-releasing hormone precursor: characterization in rat brain. Science 231:159–161[Abstract/Free Full Text]
  21. Segerson TP, Hoefler H, Childers H, Wolfe HJ, Wu P, Jackson IMD, Lechan RM 1987 Localization of thyrotropin-releasing hormone prohormone messenger ribonucleic acid in rat brain by in situ hybridization. Endocrinology 121:58–107
  22. Kakucska I, Qi Y, Clark BD, Lechan RM 1993 Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology 133:815–821[Abstract]
  23. Castro MI, Alex S, Young RA, Braverman LE, Emerson CH 1986 Total and free serum thyroid hormone concentrations in fetal and adult pregnant and nonpregnant guinea pigs. Endocrinology 118:533–537[Abstract]
  24. Braverman LE, Utiger RD (eds)1996 The Thyroid. Lippincott-Raven Pub., 7th ed., Philadelphia
  25. Lechan RM, Kakucska I 1992 Feedback regulation of thyrotropin-releasing hormone gene expression by thyroid hormone in the hypothalamic paraventricular nucleus. In: Functional Anatomy of the Neuroencocrine Hypothalamus. Wiley, Chichester, UK, pp 144–164
  26. Lechan RM 1993 Update on thyrotropin-releasing hormone. Thyroid Today XVI, No. 1
  27. Rondeel JM, de Greef WJ, Klootwijk W, Visser TJ 1992 Effects of hypothyroidism on hypothalamic release of thyrotropin-releasing hormone in rats. Endocrinology 130:651–656[Abstract]
  28. Wang PS, Huang S-W, Tung Y-F, Pu H-F, Tsai S-C, Lau C-P, Chien EJ, Chien C-H 1994 Interrelationship between thyroxine and estradiol on the secretion of thyrotropin-releasing hormone and dopamine into hypophysial portal blood in ovariectomized thyrodectomized rats. Neuroendocrinology 59:202–207[Medline]
  29. Dahl GE, Evans NP, Thrun LA, Karsh FJ 1994 A central negative feedback action of thyroid hormones on thyrotropin-releasing hormone secretion. Endocrinology 135:2392–2397[Abstract]
  30. Rondeel JMM, de Greef WJ, van der Schoot P, Karels B, Klootwijk W, Visser TJ 1988 Effect of thyroid status and paraventricular area lesions on the release of thyrotropin-releasing hormone and catecholamines into hypophysial portal blood. Endocrinology 123:523–527[Abstract]
  31. Krulich L 1982 Neurotransmitter control of thyrotropin secretion. Neuroendocrinology 35:139–147[Medline]
  32. Ishikawa K, Kakegawa T, Suzuki M 1984 Role of the hypothalamic paraventricular nucleus in the secretion of thyrotropin under adrenergic and cold-stimulated conditions in the rat. Endocrinology 114:352–358[Abstract]
  33. Arancibia S, Tapia-Arancibia L, Assenmacher I, Astier H 1985 Direct evidence of short-term cold-induced TRH release in the median eminence of unanesthetized rats. Neuroendocrinology 37:225–228
  34. Zoeller RT, Kabeer N, Albers E 1990 Cold exposure elevates cellular levels of messenger ribonucleic acid encoding thyrotropin-releasing hormone in paraventricular nucleus despite elevated levels of thyroid hormones. Endocrinology 127:2955–2962[Abstract]
  35. Uribe RM, Redondo JL, Charli J-L, Joseph-Bravo P 1993 Suckling and cold stress rapidly and transiently increase TRH mRNA in the paraventricular nucleus. Neuroendocrinology 58:140–145[Medline]
  36. Docter R, Krenning EP, de Jong M, Hennemann G 1993 The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxf) 39:499–518[Medline]
  37. Reichlin S, Glaser RJ 1958 Thyroid function in experimental streptococcal pneumonia in the rat. J Exp Med 107:219–236[Abstract]
  38. Gardner D, Kaplan MM, Stanley CA, Utiger RD 1979 Effect of triiodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med 300:579–584[Abstract]
  39. Brent GA, Hershman JM 1986 Thyroxine therapy in patients with severe nonthyroidal illness and low serum thyroxine concentration. J Clin Endocrinol Metab 63:1–8[Abstract]
  40. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV 1996 Leptin: the tale of an obesity gene. Diabetes 45:1455–1462[Medline]
  41. Ishikawa K, Taniguchi Y, Kurosumi K, Suzuki M 1986 Origin of septal thyrotropin-releasing hormone in the rat. Neuroendocrinology 44:54–58[Medline]
  42. Emerson CH, Cohen JH, Young RA, Alex S, Fang SL 1990 Gender-related differences of serum thyroxine binding proteins in the rat. Acta Endocrinol (Copenh) 123:72–78[Medline]
  43. Taylor T, Wondisford FE, Blaine T, Weintraub BD 1990 The paraventricular nucleus of the hypothalamus has a major role in thyroid hormone feedback regulation of thyrotropin synthesis and secretion. Endocrinology 126:317–324[Abstract]
  44. Taylor T, Weintraub BD 1989 Altered thyrotropin (TSH) carbohydrate structures in hypothalamic hypothyroidism created by paraventricular nuclear lesions are corrected by in vivo TSH-releasing hormone administration. Endocrinology 125:2198–2203[Abstract]
  45. Amr S, Menezes-Ferreira M, Shimohigashi Y, Chen HC, Nisula B, Weintraub BD 1985 Activities of deglycosylated thyrotropin at the thyroid membrane receptor-adenylate cyclase system. J Endocrinol Invest 8:537–541[Medline]
  46. Emerson CH 1985 Central hypothyroidism and hyperthyroidism. In: Kaplan MM, Larsen PR (eds) Symposium on Thyroid Disease, Medical Clinics of North America 69:1019–1034
  47. Beck-Peccoz P, Amr S, Menezes-Ferreira M, Faglia G, Weintraub BD 1985 Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism: effect of treatment with thyrotropin-releasing hormone. N Engl J Med 312:1085–1090[Abstract]
  48. Ambach G, Palkovits M 1978 Blood supply of the rat hypothalamus. II. Nucleus paraventricularis. Acta Morphol Hung 22:311–320
  49. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM 1996 Leptin enters the brain by a saturable system independent of insulin. Peptides 17:305–311[CrossRef][Medline]
  50. Lynn RB, Cao G-Y, Considine RV, Hyde TM, Caro JF 1996 Autoradiographic localization of leptin binding in the choroid plexus of ob/ob and db/db mice. Biochem Biophys Res Comm 219:884–889[CrossRef][Medline]
  51. Devos R, Richards JG, Campfield LA, Tartaglia LA, Guisez Y, Van der Heyden J, Travernier J, Plaetinck G, Burn P 1996 OB protein binds specifically to the choroid plexus of mice and rats. Proc Natl Acad Sci USA 93:5668–5673[Abstract/Free Full Text]
  52. Malik KF, Young III WS 1996 Localization of binding sites in the central nervous system for leptin (OB protein) in normal, obese (ob/ob), and diabetic (db/db) C57BL/6J mice. Endocrinology 137:1497–1500[Abstract]
  53. Hisano S, Fukui Y, Chikamori-Aoyama M, Aizawa T, Shibasaki T 1993 Reciprocal synaptic relations between CRF-immunoreactive-and TRH-immunoreactive neurons in the paraventricular nucleus of the rat hypothalamus. Brain Res 620:343–346[CrossRef][Medline]
  54. Mitsuma T, Nogimori T, Hirooka Y 1987 Effects of growth hormone-releasing hormone and corticotropin-releasing hormone on the release of thyrotropin-releasing hormone from the rat hypothalamus in vitro. Exp Clin Endocrinol 90:365–368[Medline]
  55. Woodward CJH, Hervey GR, Oakley RE, Whitaker EM 1991 The effect of fasting on plasma corticosterone kinetics in rats. Br J Nutr 66:117–127[CrossRef][Medline]
  56. Garcia-Belenguer S, Oliver C, Mormede P 1993 Facilitation and feedback in the hypothalamo-pituitary-adrenal axis during food restriction. J Neurendocrinol 5:663–668[CrossRef][Medline]
  57. Mitev Y, Almeida OFX, Patchev V 1993 Pituitary-adrenal function and hypothalamic beta-endorphin release in vitro following food deprivation. Brain Res Bull 30:7–10[CrossRef][Medline]
  58. Kakucska I, Qi Y, Lechan RM 1995 Changes in adrenal status affect hypothalamic thyrotropin-releasing hormone gene expression in parallel with corticotropin-releasing hormone. Endocrinology 136:2795–2802[Abstract]
  59. Stephens TW, Bristow PK, Blue-Valleskey JM, Burgett SG, Creft L, Hale J, Hoffman J, Hsiung HM, Kriaciunas A, MacKellar W, Rosteck Jr PR, Schoner B, Smith D, Tinsley FC, Zhang XY, Heiman M 1995 The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377:530–532[CrossRef][Medline]
  60. White JD, Kershaw M 1989 Increased hypothalamic neuropeptide Y expression following food deprivation. Mol Cell Neurosci 1:41–48
  61. Brady LS, Smith MA, Gold PW, Herkenham M 1990 Altered expression of hypothalamic neuropeptide mRNAs in food restricted and food-deprived rats. Neuroendocrinology 52:441–447[Medline]
  62. Sanacora G, Kershaw M, Finkelstein JA, White JD 1990 Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 127:730–737[Abstract]
  63. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D, Woods SC, Seeley RJ, Weigle DS 1996 Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 3:44–50
  64. Glaum SR, Hara M, Bindokas VP, Lee CC, Polonsky KS, Bell GI, Miller RJ 1996 Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus. Mol Pharmacol 50:230–235[Abstract]
  65. Bai FL, Yamano M, Shiotani Y, Emson PC, Smith AD, Powell JF, Tohyama M 1985 An acruato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res 33:172–175
  66. Stanley BG, Leibowitz SF 1984 Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 35:2635–2642[CrossRef][Medline]
  67. Toni R, Jackson IMD, Lechan RM 1990 Neuropeptide Y-immunoreactive innervation of thyrotropin-releasing hormone-synthesizing neurons in the rat hypothalamic paraventricular nucleus. Endocrinology 126:2444–2453[Abstract]
  68. Dubois J-M, Dayer J-M, Siegrist-Kaiser CA, Burger AG Human recombinant interleukin-1ß decreases plasma thyroid hormone and thyroid stimulating hormone levels in rats. Endocrinology 123:2175–2181
  69. Van der Poll R, Romijin JA, Wiersinga WM, Sauerwein HP 1990 Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 71:1567–1572[Abstract]
  70. Pang X-P, Hershman JM, Mirell CJ, Pekary AE 1989 Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-{alpha} (cachectin). Endocrinology 125:76–84[Abstract]
  71. Kakucska I, Romero LI, Clark BD, Rondeel JMM, Qi Y, Alex S, Emerson CH, Lechan RM 1994 Suppression of thyrotropin-releasing hormone gene expression by interleukin-1-beta in the rat: implications for nonthyroidal illness. Neuroendocrinology 59:129–137[CrossRef][Medline]
  72. Grunfeld C, Zhao C, Fuller J, Pollack A, Moser A, Friedman J, Feingold KR 1996 Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. A role for leptin in the anorexia of infection. J Clin Invest 97:2151–2157



This article has been cited by other articles:


Home page
J EndocrinolHome page
R. L. Araujo, B. M. de Andrade, A. S. P. de Figueiredo, M. L. da Silva, M. P. Marassi, V. dos Santos Pereira, E. Bouskela, and D. P Carvalho
Low replacement doses of thyroxine during food restriction restores type 1 deiodinase activity in rats and promotes body protein loss
J. Endocrinol., July 1, 2008; 198(1): 119 - 125.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
R. E. Weiss and R. L. Brown
Doctor . . . Could It Be My Thyroid?
Arch Intern Med, March 24, 2008; 168(6): 568 - 569.
[Full Text] [PDF]


Home page
J EndocrinolHome page
S C P Dutra, E G Moura, A L Rodrigues, P C Lisboa, I Bonomo, F P Toste, and M C F Passos
Cold exposure restores the decrease in leptin receptors (OB-Rb) caused by neonatal leptin treatment in 30-day-old rats
J. Endocrinol., November 1, 2007; 195(2): 351 - 358.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Perello, R. C. Stuart, C. A. Vaslet, and E. A. Nillni
Cold Exposure Increases the Biosynthesis and Proteolytic Processing of Prothyrotropin-Releasing Hormone in the Hypothalamic Paraventricular Nucleus via {beta}-Adrenoreceptors
Endocrinology, October 1, 2007; 148(10): 4952 - 4964.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. D. Knudson, G. M. Dick, and J. D. Tune
Adipokines and Coronary Vasomotor Dysfunction
Experimental Biology and Medicine, June 1, 2007; 232(6): 727 - 736.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
P. R Buff, N. T Messer IV, A. M Cogswell, D. A Wilson, P. J Johnson, D. H Keisler, and V. K Ganjam
Induction of pulsatile secretion of leptin in horses following thyroidectomy
J. Endocrinol., February 1, 2007; 192(2): 353 - 359.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Hashimoto, Y. Azuma, M. Kawasaki, H. Fujihara, E. Onuma, H. Yamada-Okabe, Y. Takuwa, E. Ogata, and Y. Ueta
Parathyroid Hormone-Related Protein Induces Cachectic Syndromes without Directly Modulating the Expression of Hypothalamic Feeding-Regulating Peptides
Clin. Cancer Res., January 1, 2007; 13(1): 292 - 298.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A Boelen, J Kwakkel, W M Wiersinga, and E Fliers
Chronic local inflammation in mice results in decreased TRH and type 3 deiodinase mRNA expression in the hypothalamic paraventricular nucleus independently of diminished food intake
J. Endocrinol., December 1, 2006; 191(3): 707 - 714.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. O. Huising, E. J. W. Geven, C. P. Kruiswijk, S. B. Nabuurs, E. H. Stolte, F. A. T. Spanings, B. M. L. Verburg-van Kemenade, and G. Flik
Increased Leptin Expression in Common Carp (Cyprinus carpio) after Food Intake But Not after Fasting or Feeding to Satiation
Endocrinology, December 1, 2006; 147(12): 5786 - 5797.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
R THOMAS ZOELLER
Collision of Basic and Applied Approaches to Risk Assessment of Thyroid Toxicants.
Ann. N.Y. Acad. Sci., September 1, 2006; 1076: 168 - 190.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
T. Komatsu, T. Chiba, H. Yamaza, K. To, H. Toyama, Y. Higami, and I. Shimokawa
Effect of leptin on hypothalamic gene expression in calorie-restricted rats.
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2006; 61(9): 890 - 898.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A Boelen, J Kwakkel, X G Vos, W M Wiersinga, and E Fliers
Differential effects of leptin and refeeding on the fasting-induced decrease of pituitary type 2 deiodinase and thyroid hormone receptor {beta}2 mRNA expression in mice.
J. Endocrinol., August 1, 2006; 190(2): 537 - 544.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Perello, R. C. Stuart, and E. A. Nillni
The Role of Intracerebroventricular Administration of Leptin in the Stimulation of Prothyrotropin Releasing Hormone Neurons in the Hypothalamic Paraventricular Nucleus
Endocrinology, July 1, 2006; 147(7): 3296 - 3306.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Fekete, P. S. Singru, E. Sanchez, S. Sarkar, M. A. Christoffolete, R. S. Riberio, W. M. Rand, C. H. Emerson, A. C. Bianco, and R. M. Lechan
Differential Effects of Central Leptin, Insulin, or Glucose Administration during Fasting on the Hypothalamic-Pituitary-Thyroid Axis and Feeding-Related Neurons in the Arcuate Nucleus
Endocrinology, January 1, 2006; 147(1): 520 - 529.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Kok, F. Roelfsema, M. Frolich, A. E. Meinders, and H. Pijl
Spontaneous Diurnal Thyrotropin Secretion Is Enhanced in Proportion to Circulating Leptin in Obese Premenopausal Women
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6185 - 6191.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. E. McMinn, S.-M. Liu, H. Liu, I. Dragatsis, P. Dietrich, T. Ludwig, C. N. Boozer, and S. C. Chua Jr.
Neuronal deletion of Lepr elicits diabesity in mice without affecting cold tolerance or fertility
Am J Physiol Endocrinol Metab, September 1, 2005; 289(3): E403 - E411.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.